arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

IN8BIO, INC.

INAB

$0.94 ▼ -0.02 (-2.48%) at close

26 Visible periods

17 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

IN8BIO, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $18.3M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -17.7% ↘

FCF / Share $-0.25

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-5.09M

↑ +8.3% —

FCF / Share Free cash flow per share

$-0.25

↓ -579.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-271.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	74.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-466.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-552.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	65.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-390.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	34.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-47.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-36.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	8.3% Fair ↓ Fair Declining Year-over-year change in net income	19.8% Good ↓ Good Declining Year-over-year change in net income	35.2% Excellent ↑ Excellent Improving Year-over-year change in net income	35.2% Excellent ↑ Excellent Improving Year-over-year change in net income	35.2% Excellent ↑ Excellent Improving Year-over-year change in net income	18.9% Good ↑ Good Improving Year-over-year change in net income	-11.0% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↑ Weak Improving Year-over-year change in net income	2.6% Caution ↑ Caution Improving Year-over-year change in net income	-25.5% Weak → Weak Stable Year-over-year change in net income	-22.5% Weak ↑ Weak Improving Year-over-year change in net income	-22.5% Weak ↑ Weak Improving Year-over-year change in net income	-33.3% Weak ↑ Weak Improving Year-over-year change in net income	-160.1% Weak → Weak Stable Year-over-year change in net income	-160.1% Weak ↓ Weak Declining Year-over-year change in net income	-160.1% Weak ↓ Weak Declining Year-over-year change in net income	-153.1% Weak ↓ Weak Declining Year-over-year change in net income	-39.7% Weak Weak Year-over-year change in net income	-39.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-579.5% Weak Weak Year-over-year change in free cash flow	—	—	—	79.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	41.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.69x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.26x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-17.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-35.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	10.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	11.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	8.9% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	16.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-19.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-22.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-26.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-17.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-11.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-22.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	-17.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-42.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-36.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-40.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-367%)	-42.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-384%)	-99.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-765%)	-62.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-519%)	-48.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-426%)	-30.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-303%)	-43.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-390%)	-34.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-44.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-399%)	-34.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-20.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-23.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-254%)	-18.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-15.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	11.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-26%)	12.7% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-15%)	13.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	11.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-24%)	12.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.26	$-0.26	$-0.85	$-1.24	$-0.07	$-1.03	$-0.15	$-0.19	$-0.20	$-0.21	$-0.23	$-0.27	$-0.30	$-0.31	$-0.34	$-0.38	—	$-0.21	$-0.25	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.25	—	$-0.78	$-0.95	$-0.04	—	—	—	$-0.18	—	—	—	$-0.32	—	—	—	—	—	$-0.48	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.31	$2.82	$2.87	$3.74	$0.17	$5.99	$0.18	$0.29	$0.40	$0.58	$0.56	$0.71	$0.67	$0.93	$1.21	$1.41	$1.75	$2.03	$3.22	$-5.64	—	$-4.40	—	—	—	—
Tangible Book Value per Share (USD)	$2.31	$2.82	$2.87	$3.74	$0.17	$5.99	$0.18	$0.29	$0.40	$0.58	$0.56	$0.71	$0.67	$0.93	$1.21	$1.41	$1.75	$2.03	$3.22	$-5.64	—	$-4.40	—	—	—	—
Basic Weighted Avg Shares (shares)	19.47M	—	4.54M	4.12M	83.48M	—	47.32M	45.13M	43.29M	—	31.55M	28.47M	24.73M	—	21.66M	18.83M	—	—	13.38M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$20.50M	$24.72M	$10.06M	$11.79M	$9.77M	$9.49M	$3.07M	$7.92M	—	$19.23M	$11.86M	$15.68M	$10.65M	$16.41M	$24.75M	$24.03M	$31.21M	$36.72M	—	$9.39M	—	$15.57M	—	—	—	—
Total Equity (USD)	$22.78M	$27.56M	$13.19M	$15.24M	$13.88M	$14.48M	$8.59M	$13.62M	$17.53M	$24.94M	$17.76M	$21.80M	$16.79M	$22.73M	$29.56M	$26.57M	$32.84M	$38.18M	$43.04M	$-21.24M	$-18.58M	$-16.58M	$-14.88M	$-13.57M	$-10.71M	$-9.24M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$245.00K	$245.00K	$200.00K	$300.00K	$256.00K	$251.00K	$300.00K	$200.00K	$239.00K	$237.00K	$200.00K	$243.00K	$243.00K	$76.00K	$33.00K	$22.00K	$16.00K	$22.00K	$22.00K	$22.00K	$22.00K	$22.00K	$22.00K	$22.00K	—	—
Net Income, GAAP (USD)	$-5.09M	$-4.94M	$-5.55M	$-5.55M	$-5.55M	$-6.16M	$-8.56M	$-8.56M	$-8.56M	$-7.60M	$-7.71M	$-7.53M	$-7.53M	$-7.80M	$-6.14M	$-6.14M	$-6.14M	$-5.85M	$-2.36M	$-2.36M	$-2.36M	$-2.31M	$-1.69M	$-1.69M	—	—
Operating Cash Flow (USD)	$-4.95M	$-2.14M	$-3.52M	$-3.93M	$-3.12M	$-4.03M	—	—	$-7.92M	$-4.85M	—	—	$-7.44M	$-7.95M	—	—	$-4.56M	$-2.18M	$-6.37M	—	$-2.51M	$-1.73M	$-2.12M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

IN8BIO, INC.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INAB with peers